تجاوز إلى المحتوى الرئيسي

بحث

عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
"An open-label extension study of the long-term safety,tolerability and efficacy of Ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension(CTEPH)." GSK Terminated Ambrisentan 3 116457 King Fahad Medical City (Riyadh)
A Compartive Multicenter Study of Neoadjuvant Docetaxel/Cisplatin Followed by Concurrent Cisplatin with Radiotherapy using Intensity-Modulated Radition Therapy (IMRT) with or without Bevacizumab for Locally Advanced Nasopharyngeal Cancer King Fahad Medical City Terminated Docetaxel/Cisplatin and Bevacizumab 3 Version 1.3 date 6 may 2012 King Fahad Medical City (Riyadh), Prince Sultan Military Medical City (Riyadh)
"A Phase III, Multicenter, Randomized, Open-Lable Clinical Trial Comparing the Efficacy and Safety of MK-0431 A (the Fixed-Dose Combination of Sitagliptin and Metformin) to That of Liraglutide in Patients With Type 2 Diabetes Mellitus" MSD Terminated MK-0431A (Sitagliptin / Metformin) vs Liraglutide 3 MK-0431A-180-00 King Khalid University Hospital (Riyadh)
Efficacy of lntra-cervical Misoprostol in the Management of Early Pregnancy Failure: Randumized Clinical Trial King Abdulaziz University Hospital Rejected Misoprostol 2 227-15 King Abdulaziz University Hospital (Jeddah)
An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients Alcon Completed Travoprost 0.004% 1 C-12-009 King Khaled Eye Specialist Hospital (Riyadh)
"Randomized, Open Label, Non-inferiority Study of Micafungin Versus Standard Care for the Prevention of Invasive Fungal Disease in High Risk Liver Transplant Recipients" Astellas Completed • Micafungin• Fluconazole• Liposomal Amphotericin B• Caspofungin 3b 9463EC0001 King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh)
A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing Assisted Reproductive Technique (ART) Merck Serono Terminated Lutropin alfa 3b EMR200061_506 King Abdulaziz University Hospital (Jeddah)
A Phase 3, Double-Blind, Randomized, Efficacy and Safety Comparison of Prasugrel and Placebo in Pediatric Patients With Sickle Cell Disease. Eli Lilly Terminated Prasugrel 3 H7T-MC-TADO King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh)
"A Multinational, Open Label, Randomized, Active-controlled, 3-arm Parallel Group, 24-week Study Comparing the Combination of Glimepiride and Metformin Versus Glimepiride and Metformin Alone in Patients With Type 2 Diabetes " Sanofi Terminated GLIMEPIRIDE-HOE490 3 GLIME_R_05809 King Fahad Specialist Hospital (Dammam), King Fahad Medical City (Riyadh)
SPIMACO Biosimilar Insulin Phase III Study: Clinical Efficacy and Safety SPIMACO Terminated Fastulin R / Normulin N 3 (version 1.4) Aug 2011 King Fahad Medical City (Riyadh)
عرض 111 - 120 من 421